Hiroyoshi Taniguchi

1.3k total citations
27 papers, 1.1k citations indexed

About

Hiroyoshi Taniguchi is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Hiroyoshi Taniguchi has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 10 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Hiroyoshi Taniguchi's work include Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Hiroyoshi Taniguchi is often cited by papers focused on Hepatitis C virus research (13 papers), Hepatitis B Virus Studies (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Hiroyoshi Taniguchi collaborates with scholars based in Japan, United States and Greece. Hiroyoshi Taniguchi's co-authors include Motoyuki Otsuka, Masao Omata, Naoya Kato, Masaru Moriyama, Takao Kawabe, Yasushi Shiratori, Tadashi Goto, Yujin Hoshida, Hideo Yoshida and Narayan Dharel and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Cancer Research.

In The Last Decade

Hiroyoshi Taniguchi

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroyoshi Taniguchi Japan	18	441	389	365	251	162	27	1.1k
Run–Xuan Shao Japan	21	639 1.4×	309 0.8×	571 1.6×	190 0.8×	200 1.2×	24	1.2k
Kiminori Kimura Japan	21	593 1.3×	547 1.4×	593 1.6×	351 1.4×	143 0.9×	75	1.5k
Myoung-Kuk Jang South Korea	9	245 0.6×	708 1.8×	454 1.2×	228 0.9×	296 1.8×	14	1.2k
Ryosuke Muroyama Japan	17	386 0.9×	354 0.9×	381 1.0×	225 0.9×	235 1.5×	37	1.0k
Martine Moreau France	18	477 1.1×	246 0.6×	588 1.6×	326 1.3×	119 0.7×	23	1.4k
Xiaogang Xiang China	21	507 1.1×	261 0.7×	739 2.0×	246 1.0×	102 0.6×	61	1.3k
Shuji Kanmura Japan	18	171 0.4×	218 0.6×	278 0.8×	164 0.7×	125 0.8×	83	891
Christoph P. Berg Germany	16	358 0.8×	441 1.1×	375 1.0×	265 1.1×	124 0.8×	47	1.4k
Hikari Okada Japan	21	344 0.8×	564 1.4×	381 1.0×	123 0.5×	172 1.1×	49	1.1k
Jean‐Pierre Couty France	16	259 0.6×	417 1.1×	296 0.8×	204 0.8×	248 1.5×	29	1.1k

Countries citing papers authored by Hiroyoshi Taniguchi

Since Specialization

Citations

This map shows the geographic impact of Hiroyoshi Taniguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyoshi Taniguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyoshi Taniguchi more than expected).

Fields of papers citing papers by Hiroyoshi Taniguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyoshi Taniguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyoshi Taniguchi. The network helps show where Hiroyoshi Taniguchi may publish in the future.

Co-authorship network of co-authors of Hiroyoshi Taniguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyoshi Taniguchi. A scholar is included among the top collaborators of Hiroyoshi Taniguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyoshi Taniguchi. Hiroyoshi Taniguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ohki, Takamasa, Takuma Teratani, Shinpei Sato, et al.. (2023). A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study. BMC Gastroenterology. 23(1). 250–250.

Takeda, Haruhiko, Hiroki Nishikawa, Yukio Osaki, et al.. (2015). Proposal of Japan Red Cross score for sorafenib therapy in hepatocellular carcinoma. Hepatology Research. 45(10). E130–40. 9 indexed citations

Nishikawa, Hiroki, Yukio Osaki, Haruhiko Takeda, et al.. (2014). Comparison of standard-dose and half-dose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysis. International Journal of Oncology. 45(6). 2295–2302. 20 indexed citations

Nishikawa, Hiroki, Haruhiko Takeda, Kaoru Tsuchiya, et al.. (2014). Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan. Journal of Cancer. 5(7). 499–509. 28 indexed citations

Kato, Naoya, Ryosuke Muroyama, Hiroyoshi Taniguchi, et al.. (2009). Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment. Liver International. 30(2). 311–318. 5 indexed citations

Dharel, Narayan, Naoya Kato, Ryosuke Muroyama, et al.. (2008). Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus†. Hepatology. 47(4). 1136–1149. 58 indexed citations

Hoshida, Yujin, Masaru Moriyama, Motoyuki Otsuka, et al.. (2007). Gene expressions associated with chemosensitivity in human hepatoma cells.. PubMed. 54(74). 489–92. 15 indexed citations

Moriyama, Masaru, Naoya Kato, Motoyuki Otsuka, et al.. (2007). Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, and NS5A. Hepatology International. 1(2). 302–310. 28 indexed citations

Wang, Yue, Naoya Kato, Amarsanaa Jazag, et al.. (2006). Hepatitis C Virus Core Protein Is a Potent Inhibitor of RNA Silencing-Based Antiviral Response. Gastroenterology. 130(3). 883–892. 92 indexed citations

10.

Kato, Naoya, Guijin Ji, Yue Wang, et al.. (2005). Large-Scale Search of Single Nucleotide Polymorphisms for Hepatocellular Carcinoma Susceptibility Genes in Patients With Hepatitis C *. Hepatology. 42(4). 846–853. 52 indexed citations

11.

Otsuka, Motoyuki, Naoya Kato, Masaru Moriyama, et al.. (2005). Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses†. Hepatology. 41(5). 1004–1012. 103 indexed citations

12.

Shao, Run–Xuan, Motoyuki Otsuka, Naoya Kato, et al.. (2005). Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways. Gastroenterology. 128(1). 86–95. 36 indexed citations

13.

Otsuka, Motoyuki, Naoya Kato, Run–Xuan Shao, et al.. (2004). Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation. Hepatology. 40(1). 243–251. 103 indexed citations

14.

Taniguchi, Hiroyoshi, Naoya Kato, Motoyuki Otsuka, et al.. (2003). Hepatitis C virus core protein upregulates transforming growth factor‐β1 transcription. Journal of Medical Virology. 72(1). 52–59. 103 indexed citations

15.

Kato, Naoya, Yujin Hoshida, Hideo Yoshida, et al.. (2003). Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology. 37(1). 65–71. 146 indexed citations

16.

Moriyama, Masaru, Yujin Hoshida, Motoyuki Otsuka, et al.. (2003). Relevance network between chemosensitivity and transcriptome in human hepatoma cells.. PubMed. 2(2). 199–205. 42 indexed citations

17.

Otsuka, Motoyuki, Naoya Kato, Hiroyoshi Taniguchi, et al.. (2002). Hepatitis C Virus Core Protein Inhibits Apoptosis via Enhanced Bcl-xL Expression. Virology. 296(1). 84–93. 57 indexed citations

18.

Kato, Jun, Naoya Kato, Masaru Moriyama, et al.. (2002). Interferons Specifically Suppress the Translation from the Internal Ribosome Entry Site of Hepatitis C Virus through a Double‐Stranded RNA–Activated Protein Kinase–Independent Pathway. The Journal of Infectious Diseases. 186(2). 155–163. 20 indexed citations

19.

Hoshida, Yujin, Masaru Moriyama, Motoyuki Otsuka, et al.. (2002). Identification of genes associated with sensitivity to 5-fluorouracil and cisplatin in hepatoma cells. Journal of Gastroenterology. 37(S14). 92–95. 8 indexed citations

20.

Ohashi, Makoto, Fumihiko Kanai, Keisuke Tateishi, et al.. (2001). Target Gene Therapy for α-Fetoprotein-Producing Hepatocellular Carcinoma by E1B55k-Attenuated Adenovirus. Biochemical and Biophysical Research Communications. 282(2). 529–535. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact